二甲双胍
神经炎症
安普克
神经保护
神经发生
小胶质细胞
海马体
淀粉样前体蛋白
医学
炎症
PI3K/AKT/mTOR通路
内分泌学
阿尔茨海默病
神经科学
内科学
信号转导
生物
糖尿病
蛋白激酶A
激酶
细胞生物学
疾病
作者
Zhenri Ou,Xuejian Kong,Xiangdong Sun,Xiaosong He,Le Zhang,Zhuo Gong,Jingyi Huang,Biao Xu,Dahong Long,Jianhua Li,Qingqing Li,Liping Xu,Aiguo Xuan
标识
DOI:10.1016/j.bbi.2017.12.009
摘要
Alzheimer's disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques, neurofibrillary tangles, and neuronal loss, accompanied by neuroinflammation. Neuroinflammatory processes are thought to contribute to AD pathophysiology. Metformin has been reported to have anti-inflammatory efficacy. However, whether metformin is responsible for the anti-neuroinflammation and neuroprotection on APPswe/PS1ΔE9 (APP/PS1) mice remains unclear. Here we showed that metformin attenuated spatial memory deficit, neuron loss in the hippocampus and enhanced neurogenesis in APP/PS1 mice. In addition, metformin administration decreased amyloid-β (Aβ) plaque load and chronic inflammation (activated microglia and astrocytes as well as pro-inflammatory mediators) in the hippocampus and cortex. Further study demonstrated that treatment with metformin enhanced cerebral AMPK activation. Meanwhile, metformin notably suppressed the activation of P65 NF-κB, mTOR and S6K, reduced Bace1 protein expression. Our data suggest that metformin can exert functional recovery of memory deficits and neuroprotective effect on APP/PS1 mice via triggering neurogenesis and anti-inflammation mediated by regulating AMPK/mTOR/S6K/Bace1 and AMPK/P65 NF-κB signaling pathways in the hippocampus, which may contribute to improvement in neurological deficits.
科研通智能强力驱动
Strongly Powered by AbleSci AI